TMCnet2h
PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality
"We are excited to collaborat with PHC to unlock new possibilities in cell culture," explained Michael May, President and CEO ...
Building better biomaterials for cancer treatments
Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could ...
Contract Pharma2d
Cell and Gene Therapy Manufacturing Challenges & Solutions
According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...
Two cancer surgeons each receive $6m research award to study cancers prevalent in Singapore
That is about to change, with $6 million awarded to National Cancer Centre Singapore (NCCS) senior consultant surgeon Pierce ...
studyfinds3d
Personalized vaccines halt kidney cancer after encouraging phase 1 trial
Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...
manilatimes4d
NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization
Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...
Pharmaceutical Technology4d
Italian charity seeks EMA approval for rescued gene therapy
Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.
Pharmaceutical Technology6d
Rentschler closes UK cell and gene therapy facility and does a pivot to biologics
CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...